Acumen Pharmaceuticals (ABOS) Interest Coverage Ratio (QoQ) (2021 - 2026)
Acumen Pharmaceuticals (ABOS) Interest Coverage Ratio (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Acumen Pharmaceuticals | 226.87 Mn | 226.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50.42% |
| Mar 31, 2026 | 42.53% |
| Dec 31, 2025 | -38.67% |
| Sep 30, 2025 | 37.80% |
| Jun 30, 2025 | -34.45% |
| Mar 31, 2025 | -36.45% |
| Dec 31, 2024 | 30.75% |
| Sep 30, 2024 | -29.37% |
| Jun 30, 2024 | -36.63% |
| Mar 31, 2024 | 83.75% |
| Jun 30, 2023 | -2.61% |
| Mar 31, 2023 | -362.74% |
| Dec 31, 2022 | 43,865.29% |
| Sep 30, 2022 | 65.71% |
| Jun 30, 2022 | 99.66% |
| Mar 31, 2022 | -166.22% |
| Dec 31, 2021 | 313.85% |
| Sep 30, 2021 | -256,580.15% |